Spinal Tumor Clinical Trials
The following trials for the treatment of various spinal cancer conditions are available for your participation. Click on the study number to view details of eligibility criteria.
Last updated 10/15/13
CERN09-02: Phase II Trial of Carboplatin and Bevacizumab for the Treatment of Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial and Spinal cord Ependymoma in Adults
Principal Investigator: Mark R. Gilbert, M.D.
The goal of this clinical research study is to learn if the combination of bevacizumab and carboplatin can help to control recurrent ependymoma. The safety of this drug combination will also be studied.